Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01550133 · ClinicalTrials.gov registry record · NA
Effects of Food Form on Cephalic Phase Responses
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01550133: Completed NA study, sponsored by Purdue University.
NCT01550133 is a NA study that has completed, run by Purdue University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01550133, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study has two main aims: 1) To determine if ingestion of solid or beverage food forms will change appetite hormone responses, and 2) To determine whether "learning" (defined as 2 week daily consumption) about the metabolic consequence of ingesting solid or beverage foods forms varying in energy alters appetite hormone responses. Beverage consumption has been implicated in the problem of obesity. However, the exact relationship between beverages, lower appetitive response and lower compensatory dietary responses remains unclear. This study aims to address this gap in the research. For aim 1, the null hypothesis is that the energy in beverage and solid forms will not affect appetite hormonal responses differently. The alternative hypothesis is that exposure to the energy-yielding beverage will elicit a lower appetitive hormone response compared to oral exposure to the solid food form. For aim 2, the null hypothesis is that learning will not change appetite hormone responses. The alternative hypothesis is that learning will decrease appetite hormone responses in the non-energy-yielding beverage more than in the energy-yielding beverage.
Primary Outcome
Determine the appetite hormone responses to oral exposure of nutritive (energy-yielding) or non-nutritive (non-energy-yielding) sweetener in beverage or solid form. Then, determine whether the appetite hormone responses change after a 2-week learning period. Appetite hormones to be measured: Cholecystokinin, Glucagon-Like-Peptide-1, Ghrelin, Insulin, Pancreatic Polypeptide
Interventions
- BEHAVIORAL Learned: Non-nutritive beverage to Non-nutritive beverage
- BEHAVIORAL Learned: Nutritive solid to Nutritive solid
- BEHAVIORAL Learned: Nutritive beverage to Nutritive beverage
- BEHAVIORAL Not Learned: Non-nutritive solid to Nutritive solid
- BEHAVIORAL Not Learned: Nutritive beverage to Non-nutritive beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-09-01 |
| Est. Completion | 2016-12-30 |
| Phase | NA |
What the finished NCT01550133 record still lists
NCT01550133 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which Learned: Non-nutritive beverage to Non-nutritive beverage is the first listed.
NCT01550133 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01550133 about?
NCT01550133 is a clinical study titled "Effects of Food Form on Cephalic Phase Responses". This study has two main aims: 1) To determine if ingestion of solid or beverage food forms will change appetite hormone responses, and 2) To determine whether "learning" (defined as 2 week daily consumption) about the metabolic consequence of ingesting solid or beverage foods forms varying in energy...
What is the current status of trial NCT01550133?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2012-09-01. Estimated completion is 2016-12-30.
What interventions are being tested in trial NCT01550133?
The interventions under investigation include: Learned: Non-nutritive beverage to Non-nutritive beverage (BEHAVIORAL), Learned: Nutritive solid to Nutritive solid (BEHAVIORAL), Learned: Nutritive beverage to Nutritive beverage (BEHAVIORAL), Not Learned: Non-nutritive solid to Nutritive solid (BEHAVIORAL), Not Learned: Nutritive beverage to Non-nutritive beverage (BEHAVIORAL).
Who is sponsoring clinical trial NCT01550133?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01550133's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI